4 hours ago
BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial in patients with metastatic squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy. Reuters said gotistobart nearly doubled survival compared with standard-of-care chemotherapy, strengthening the case for the drug as a potential chemotherapy-free treatment in a population with significant unmet need.
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ****** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.
#stage #survival
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ****** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.
#stage #survival
6 days ago
Unlike Medicare Advantage, Medigap offers no recurring annual shopping window, so health conditions can permanently lock policyholders into higher premiums.
The one-time federal Medigap Open Enrollment Period lasts just six months starting at age 65; after that, most states allow medical underwriting.
Never cancel an existing Medigap policy before a replacement is confirmed in writing, since a declined application leaves the original coverage intact.
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
A 72-year-old in Ohio opens a December rate notice and finds that her Medigap Plan G premium is rising again in January, the fourth increase in four years. Her broker finds a competitor charging $40 less each month.
#finds #period
The one-time federal Medigap Open Enrollment Period lasts just six months starting at age 65; after that, most states allow medical underwriting.
Never cancel an existing Medigap policy before a replacement is confirmed in writing, since a declined application leaves the original coverage intact.
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
A 72-year-old in Ohio opens a December rate notice and finds that her Medigap Plan G premium is rising again in January, the fourth increase in four years. Her broker finds a competitor charging $40 less each month.
#finds #period
9 days ago
CNBC reported that NVIDIA Corporation (NASDAQ:NVDA) CFO Colette Kress told investors on August 26 that fiscal 2028 revenue growth will reach 70%, far above the 44% average **** yst estimate tracked by LSEG, marking the company's first-ever year-ahead revenue forecast.
Applied to the roughly $396 billion consensus estimate for fiscal 2027, that guidance implies fiscal 2028 revenue near $673 billion to $700 billion. It would put Nvidia ahead of Apple and Alphabet and behind only Amazon among U.S. tech companies by revenue. The forecast followed fiscal second-quarter results that beat expectations across the board: revenue more than doubled to $96.22 billion, up 106% year over year, with data center revenue of $89 billion, up 117%, now making up 92% of total sales.
CEO Jensen Huang told investors AI has reached the point where it is doing productive, profitable work and that computing capacity itself is now translating directly into revenue. Shares jumped roughly 8.7% on the news, lifting the broader semiconductor sector. Management said the 70% figure shows supply constraints, primarily memory component shortages, rather than a ceiling on actual demand, and the outlook excludes China data center revenue.
The current quarter already delivered, not just promised. Revenue of $96.22 billion beat estimates by roughly $4 billion, and data center revenue's 117% year-over-year jump shows the AI buildout is generating historic growth today, not just in a projection.
NVIDIA Corporation (NASDAQ:NVDA)'s customer base is broadening, which could reduce concentration risk. Huang said demand is now coming from hyperscale cloud providers alongside sovereign AI programs, neoclouds, AI startups, and enterprises. It means future growth depends less on any single large customer's spending decisions.
#year #corporation
Applied to the roughly $396 billion consensus estimate for fiscal 2027, that guidance implies fiscal 2028 revenue near $673 billion to $700 billion. It would put Nvidia ahead of Apple and Alphabet and behind only Amazon among U.S. tech companies by revenue. The forecast followed fiscal second-quarter results that beat expectations across the board: revenue more than doubled to $96.22 billion, up 106% year over year, with data center revenue of $89 billion, up 117%, now making up 92% of total sales.
CEO Jensen Huang told investors AI has reached the point where it is doing productive, profitable work and that computing capacity itself is now translating directly into revenue. Shares jumped roughly 8.7% on the news, lifting the broader semiconductor sector. Management said the 70% figure shows supply constraints, primarily memory component shortages, rather than a ceiling on actual demand, and the outlook excludes China data center revenue.
The current quarter already delivered, not just promised. Revenue of $96.22 billion beat estimates by roughly $4 billion, and data center revenue's 117% year-over-year jump shows the AI buildout is generating historic growth today, not just in a projection.
NVIDIA Corporation (NASDAQ:NVDA)'s customer base is broadening, which could reduce concentration risk. Huang said demand is now coming from hyperscale cloud providers alongside sovereign AI programs, neoclouds, AI startups, and enterprises. It means future growth depends less on any single large customer's spending decisions.
#year #corporation
12 days ago
The S&P 500 has delivered double-digit gains in 2026, and the rally has outlasted every warning thrown at it so far. One of Wall Street's most closely tracked positioning gauges is now flashing a different signal.
Bank of America's proprietary Bull & Bear Indicator has remained in sell-signal territory since May 2026, with July weekly readings ranging from 9.5 to 9.6 on a 10-point scale, Business Insider showed.
Those are the highest levels seen since 2021, driven by extreme positioning across hedge funds, fund managers, equity flows, and credit-market technicals.
"Extreme bull positioning says reduce risk exposure," Bank of America chief investment strategist Michael Hartnett said in a client note, Business Insider reported.
The signal does not guarantee a decline, and prior sell triggers have sometimes fizzled without producing meaningful losses. But the buyer pool has thinned enough that even modest earnings or policy disappointment can spark outsized selling pressure.
#insider #extreme #sell
Bank of America's proprietary Bull & Bear Indicator has remained in sell-signal territory since May 2026, with July weekly readings ranging from 9.5 to 9.6 on a 10-point scale, Business Insider showed.
Those are the highest levels seen since 2021, driven by extreme positioning across hedge funds, fund managers, equity flows, and credit-market technicals.
"Extreme bull positioning says reduce risk exposure," Bank of America chief investment strategist Michael Hartnett said in a client note, Business Insider reported.
The signal does not guarantee a decline, and prior sell triggers have sometimes fizzled without producing meaningful losses. But the buyer pool has thinned enough that even modest earnings or policy disappointment can spark outsized selling pressure.
#insider #extreme #sell
16 days ago
Roblox is down 49% year to date and slipping another 3% as Cathie Wood's ARK keeps trimming, while Take-Two barely moves ahead of GTA VI.
ARK sold $6.5M of Roblox while buying $7.6M of nuclear supplier BWXT, rotating capital from consumer platforms into AI-adjacent power infrastructure.
Roblox's 43% revenue growth and 66% free cash flow surge contrast sharply with its $1B net loss, keeping the stock's valuation under persistent pressure.
Act now: the ***** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Roblox didn't make the cut. Grab the names FREE today.
Roblox stock is falling harder than its sector fund and its top gaming peer this Tuesday morning, on a session with no company news to explain the underperformance. The identifiable pressure comes from continued selling by Cathie Wood's ARK Invest, without any overnight announcement from Roblox (NYSE:RBLX) itself. The rotation detail is the story: ARK sold Roblox on the same day it bought a nuclear supplier.
#cathie #sold #take #BWXT
ARK sold $6.5M of Roblox while buying $7.6M of nuclear supplier BWXT, rotating capital from consumer platforms into AI-adjacent power infrastructure.
Roblox's 43% revenue growth and 66% free cash flow surge contrast sharply with its $1B net loss, keeping the stock's valuation under persistent pressure.
Act now: the ***** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and Roblox didn't make the cut. Grab the names FREE today.
Roblox stock is falling harder than its sector fund and its top gaming peer this Tuesday morning, on a session with no company news to explain the underperformance. The identifiable pressure comes from continued selling by Cathie Wood's ARK Invest, without any overnight announcement from Roblox (NYSE:RBLX) itself. The rotation detail is the story: ARK sold Roblox on the same day it bought a nuclear supplier.
#cathie #sold #take #BWXT
18 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Mortgage rates have been above 6.5% for most of four months. There has been little momentum to move lower. What if we're asking the wrong question: not when will rates go down, but are they poised to move higher?
See today's best rates.
No. As of August 27, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.66%. This is one basis point higher than last week. At this time in August 2025, mortgage rates averaged 6.56%, 10 basis points lower.
The average 15-year fixed mortgage rate this week was 5.98%, up three basis points from last week, and 29 basis points higher than this time last year.
#mortgage #august
Mortgage rates have been above 6.5% for most of four months. There has been little momentum to move lower. What if we're asking the wrong question: not when will rates go down, but are they poised to move higher?
See today's best rates.
No. As of August 27, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.66%. This is one basis point higher than last week. At this time in August 2025, mortgage rates averaged 6.56%, 10 basis points lower.
The average 15-year fixed mortgage rate this week was 5.98%, up three basis points from last week, and 29 basis points higher than this time last year.
#mortgage #august
21 days ago
Diversification is a key concept of Foolish investing. These days, The Fool suggests holding at least 50 different stocks across various sectors, or achieving a similar effect through index funds.
I'm taking a hybrid approach. As of Aug. 25, my portfolio holds 56 stocks, cryptocurrencies, and exchange-traded funds (ETFs).
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The holdings aren't equal, though. Some are smaller, tentative bets. One fund is simply a higher-yielding alternative to holding cash in my brokerage account. Most are strong convictions with long ownership histories, but I hesitate to buy more in this market.
But you're here to see the stocks I'd recommend buying right now for the long haul. The ones combining robust business models with dominant market positions -- and affordable valuations. I do have a handful of those.
#NVIDIA
I'm taking a hybrid approach. As of Aug. 25, my portfolio holds 56 stocks, cryptocurrencies, and exchange-traded funds (ETFs).
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The holdings aren't equal, though. Some are smaller, tentative bets. One fund is simply a higher-yielding alternative to holding cash in my brokerage account. Most are strong convictions with long ownership histories, but I hesitate to buy more in this market.
But you're here to see the stocks I'd recommend buying right now for the long haul. The ones combining robust business models with dominant market positions -- and affordable valuations. I do have a handful of those.
#NVIDIA
22 days ago
The S&P 500 Index ($SPX) (SPY) is down by -0.27% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -1.00%. E-mini S&P futures (ESU26) are down -0.26%, and September E-mini Nasdaq futures (NQU26) are down -1.05%.
Stock indices are mixed today, with the Nasdaq 100 falling to a 3-week low. The broader market is under pressure today amid the weakness in chipmakers and AI-infrastructure stocks. Also, weighing on market sentiment was the collapse of trade talks late last Friday between Canada and the US, prompting the US to apply a 50% tariff on about $20 billion of Canadian goods. Canada announced retaliation on US goods that will take effect on September 8.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock
#Stock #NVIDIA #earnings
Stock indices are mixed today, with the Nasdaq 100 falling to a 3-week low. The broader market is under pressure today amid the weakness in chipmakers and AI-infrastructure stocks. Also, weighing on market sentiment was the collapse of trade talks late last Friday between Canada and the US, prompting the US to apply a 50% tariff on about $20 billion of Canadian goods. Canada announced retaliation on US goods that will take effect on September 8.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock
#Stock #NVIDIA #earnings
27 days ago
Is Sandisk (NASDAQ: SNDK) stock overbought... and overpriced?
Worries over a Morgan Stanley report yesterday, which compared the percentage of the S&P 500 index that is Sandisk stock versus the percentage Sandisk occupies in the portfolios of large institutional investors -- and concluded Sandisk is "over-owned" -- spooked investors yesterday. By close of trading, Sandisk stock had fallen 9%.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
As we approach the mid-day mark Wednesday, Sandisk stock continues to drift lower -- down 2.2% as of 11:30 a.m. ET.
Morgan Stanley's number-crunchers did what they do, calculating percentages and concluding that certain tech stocks, including Apple, Microsoft, and Amazon, are all "under-owned" (because institutions don't own as much of them as S&P does). Other stocks, and Sandisk in particular, are conversely "over-owned" -- because they're more popular on Wall Street.
#NVIDIA
Worries over a Morgan Stanley report yesterday, which compared the percentage of the S&P 500 index that is Sandisk stock versus the percentage Sandisk occupies in the portfolios of large institutional investors -- and concluded Sandisk is "over-owned" -- spooked investors yesterday. By close of trading, Sandisk stock had fallen 9%.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
As we approach the mid-day mark Wednesday, Sandisk stock continues to drift lower -- down 2.2% as of 11:30 a.m. ET.
Morgan Stanley's number-crunchers did what they do, calculating percentages and concluding that certain tech stocks, including Apple, Microsoft, and Amazon, are all "under-owned" (because institutions don't own as much of them as S&P does). Other stocks, and Sandisk in particular, are conversely "over-owned" -- because they're more popular on Wall Street.
#NVIDIA
29 days ago
Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Management attributed the second quarter's flat revenue to the voluntary recall of the CGuard Prime 135 system, which necessitated $734,000 in customer credits that offset underlying U.S. sales growth.
International business grew 21% year-over-year, serving as a strategic proof point for the CGuard implant's clinical efficacy and physician demand despite domestic regulatory setbacks.
The company implemented a 20% workforce reduction to align its cost structure with near-term regulatory priorities, aiming to preserve cash while maintaining a lean commercial core for relaunch.
Management emphasized that the CGuard implant itself remains the foundational value driver, with the recall being a 'well-defined and manageable' issue isolated to the delivery system rather than the stent technology.
#cguard #recall #system #international
Management attributed the second quarter's flat revenue to the voluntary recall of the CGuard Prime 135 system, which necessitated $734,000 in customer credits that offset underlying U.S. sales growth.
International business grew 21% year-over-year, serving as a strategic proof point for the CGuard implant's clinical efficacy and physician demand despite domestic regulatory setbacks.
The company implemented a 20% workforce reduction to align its cost structure with near-term regulatory priorities, aiming to preserve cash while maintaining a lean commercial core for relaunch.
Management emphasized that the CGuard implant itself remains the foundational value driver, with the recall being a 'well-defined and manageable' issue isolated to the delivery system rather than the stent technology.
#cguard #recall #system #international
1 month ago
The $4 trillion market cap club is a fairly exclusive membership body. There are only four members, and Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is one of them. However, over the next few years, I think more companies will join Alphabet, including Taiwan Semiconductor Manufacturing (NYSE: TSM) (TSMC) and Broadcom (NASDAQ: AVGO). These two hardware providers have a ton of growth ahead of them, and both of them can about double to gain entry into the club.
Finding stocks that can double in just a few years isn't easy, but I think these two are primed to do it.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
To reach the $4 trillion club, both of these companies must have some major business growth ahead, which they do. Both are major beneficiaries of AI spending, and with AI spending projected to continue rising over the next few years, these two are in great shape.
TSMC is probably the easiest winner to pick in this sector, as its logic chip fabrication processes are utilized by nearly every company in the AI computing industry, including Broadcom. TSMC will benefit as long as there is increased chip demand, which has proven true so far. During TSMC's latest earnings call, CEO C.C. Wei noted that chip demand looks strong through at least 2029 to 2030, leaving multiple years of incredible growth ahead.
#tsmc
Finding stocks that can double in just a few years isn't easy, but I think these two are primed to do it.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
To reach the $4 trillion club, both of these companies must have some major business growth ahead, which they do. Both are major beneficiaries of AI spending, and with AI spending projected to continue rising over the next few years, these two are in great shape.
TSMC is probably the easiest winner to pick in this sector, as its logic chip fabrication processes are utilized by nearly every company in the AI computing industry, including Broadcom. TSMC will benefit as long as there is increased chip demand, which has proven true so far. During TSMC's latest earnings call, CEO C.C. Wei noted that chip demand looks strong through at least 2029 to 2030, leaving multiple years of incredible growth ahead.
#tsmc
1 month ago
Dan Ives holds C3.ai's (AI) Street-high $15 target, but 13 of 14 ****** ysts rate Hold or worse with consensus implying 13% downside.
C3.ai's revenue fell 36% while peers Palantir (PLTR) and SoundHound (SOUN) posted 93% and 45% growth, making this an isolated execution story.
Siebel personally bought 6.17 million shares at $11.16 but called recent sales 'unspeakably horrible' as free cash flow deteriorated to negative $192 million.
Act now: the ****** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and C3.ai didn't make the cut. Grab the names FREE today.
C3.ai (NYSE:AI) currently trades at $10.18, while Wedbush Securities ****** yst Dan Ives carries a Street-high price target of $15 on the enterprise AI software company, implying roughly 47% upside from here. That headline number sits far above the broader Wall Street consensus, which has drifted lower after a brutal fiscal 2026.
#million
C3.ai's revenue fell 36% while peers Palantir (PLTR) and SoundHound (SOUN) posted 93% and 45% growth, making this an isolated execution story.
Siebel personally bought 6.17 million shares at $11.16 but called recent sales 'unspeakably horrible' as free cash flow deteriorated to negative $192 million.
Act now: the ****** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and C3.ai didn't make the cut. Grab the names FREE today.
C3.ai (NYSE:AI) currently trades at $10.18, while Wedbush Securities ****** yst Dan Ives carries a Street-high price target of $15 on the enterprise AI software company, implying roughly 47% upside from here. That headline number sits far above the broader Wall Street consensus, which has drifted lower after a brutal fiscal 2026.
#million
1 month ago
Japan Petroleum Exploration Co. (JAPEX) is expanding its U.S. oil and gas footprint with a $320 million acquisition of tight oil and gas producer Fundare, strengthening its position in Colorado and Wyoming as it pursues an aggressive international growth strategy.
JAPEX said it would acquire all four Fundare operating entities through its U.S.-based subsidiary structure, adding ***** ets that produced approximately 9,500 barrels of oil equivalent per day in the first quarter of 2026.
A major portion of the acquired acreage sits close to ***** EX's existing Verdad ***** ets, which the ***** anese producer acquired earlier this year. The proximity should allow ***** EX to pursue operational synergies, lower development costs and benefit from greater economies of scale.
The deal is closely aligned with ***** EX's newly launched 2026-2035 management plan, which positions the United States as a key hub for early earnings growth and for building the company's operational expertise in tight oil and gas. The company has set a target of increasing production to 100,000 boe/d by fiscal 2031 and 180,000 boe/d by 2035, with overseas E&P at the center of the strategy.
JAPEX's U.S. expansion has accelerated rapidly. Reuters reported in April that the company plans to direct more than half of its overseas E&P investment toward the United States, following its $1.3 billion acquisition of Verdad.
#fundare #tight #Growth
JAPEX said it would acquire all four Fundare operating entities through its U.S.-based subsidiary structure, adding ***** ets that produced approximately 9,500 barrels of oil equivalent per day in the first quarter of 2026.
A major portion of the acquired acreage sits close to ***** EX's existing Verdad ***** ets, which the ***** anese producer acquired earlier this year. The proximity should allow ***** EX to pursue operational synergies, lower development costs and benefit from greater economies of scale.
The deal is closely aligned with ***** EX's newly launched 2026-2035 management plan, which positions the United States as a key hub for early earnings growth and for building the company's operational expertise in tight oil and gas. The company has set a target of increasing production to 100,000 boe/d by fiscal 2031 and 180,000 boe/d by 2035, with overseas E&P at the center of the strategy.
JAPEX's U.S. expansion has accelerated rapidly. Reuters reported in April that the company plans to direct more than half of its overseas E&P investment toward the United States, following its $1.3 billion acquisition of Verdad.
#fundare #tight #Growth
1 month ago
NEW YORK (AP) — Government lawyers said a Court of International Trade judge overstepped his authority by ordering the U.S. Customs and Border Patrol to issue refunds to all companies that paid tariffs that were deemed illegal in February, even those that didn't file a lawsuit in trade court.
The government filed an appeal with the U.S. Court of Appeals for the Federal Circuit in June and filed its opening brief on Monday.
In it, government lawyers point to a case that went before the Supreme Court in June 2025, over birthright citizenship. Part of the decision in that case limited the use of universal injunctions, which apply a ruling to all people or companies affected, not just specific litigants.
Judge Richard Eaton, who is overseeing the tariff lawsuits in the Court of International Trade, has said the limits on universal injunctions don't apply in this case, but the government disagrees.
"The CIT's universal injunctions, requiring the government to refund IEEPA duties for all importers (including non-party importers), cannot possibly be squared with CASA," — the court case that limited universal injunctions, the government wrote it its brief.
#government #case #international
The government filed an appeal with the U.S. Court of Appeals for the Federal Circuit in June and filed its opening brief on Monday.
In it, government lawyers point to a case that went before the Supreme Court in June 2025, over birthright citizenship. Part of the decision in that case limited the use of universal injunctions, which apply a ruling to all people or companies affected, not just specific litigants.
Judge Richard Eaton, who is overseeing the tariff lawsuits in the Court of International Trade, has said the limits on universal injunctions don't apply in this case, but the government disagrees.
"The CIT's universal injunctions, requiring the government to refund IEEPA duties for all importers (including non-party importers), cannot possibly be squared with CASA," — the court case that limited universal injunctions, the government wrote it its brief.
#government #case #international
1 month ago
Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Achieved record second-quarter earnings with high-teens growth in adjusted EBITDA and EPS, excluding catastrophes, positioning the company to deliver its 10th consecutive year of profitable growth.
Global Lifestyle performance was bolstered by a 24% year-to-date increase in Connected Living earnings, driven by the expansion of mobile supply chain services and optimization of recently added programs.
The company is evolving from a protection provider to an end-to-end business partner, leveraging integrated ecosystems of technology, data, and AI to solve complex client challenges at scale.
Global Housing growth was supported by a new partnership with Freedom Mortgage, adding approximately 2.6 million loans to the lender-placed insurance portfolio.
#year
Achieved record second-quarter earnings with high-teens growth in adjusted EBITDA and EPS, excluding catastrophes, positioning the company to deliver its 10th consecutive year of profitable growth.
Global Lifestyle performance was bolstered by a 24% year-to-date increase in Connected Living earnings, driven by the expansion of mobile supply chain services and optimization of recently added programs.
The company is evolving from a protection provider to an end-to-end business partner, leveraging integrated ecosystems of technology, data, and AI to solve complex client challenges at scale.
Global Housing growth was supported by a new partnership with Freedom Mortgage, adding approximately 2.6 million loans to the lender-placed insurance portfolio.
#year
1 month ago
Surrendering a whole-life policy can trigger a taxable gain that spikes MAGI and pushes Medicare beneficiaries into higher IRMAA brackets two years later.
A $52,000 taxable gain hidden inside an $84,000 surrender check doubled one widow's Part B premium from $203 to $406, costing her roughly $2,885 extra that year.
Before surrendering, ask the insurer for the estimated taxable gain, add it to projected MAGI, and consider a Section 1035 exchange to defer the tax hit.
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
A 68-year-old widow surrendered a whole-life policy her late husband bought in 1988. The insurer sent her roughly $84,000. Her basis, the premiums paid over 37 years, adjusted for any prior distributions, was about $32,000. She spent the money on a kitchen remodel and a grandchild's tuition, filed her tax return, and moved on. Eighteen months later, her Medicare notice arrived. The Part B premium had doubled.
#gain #whole
A $52,000 taxable gain hidden inside an $84,000 surrender check doubled one widow's Part B premium from $203 to $406, costing her roughly $2,885 extra that year.
Before surrendering, ask the insurer for the estimated taxable gain, add it to projected MAGI, and consider a Section 1035 exchange to defer the tax hit.
Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.
A 68-year-old widow surrendered a whole-life policy her late husband bought in 1988. The insurer sent her roughly $84,000. Her basis, the premiums paid over 37 years, adjusted for any prior distributions, was about $32,000. She spent the money on a kitchen remodel and a grandchild's tuition, filed her tax return, and moved on. Eighteen months later, her Medicare notice arrived. The Part B premium had doubled.
#gain #whole
2 months ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Mortgage rates have broken above a one-year high after stalling in the mid-sixes for two months. What will it take for mortgage rates to move lower?
See today's best rates.
As of July 30, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.66%. This is eight basis points higher than last week. At this time in July 2025, mortgage rates averaged 6.72%, six basis points higher
The average 15-year fixed mortgage rate this week was 6.04%, also up eight basis points from last week, and 19 basis points higher than this time last year.
#mortgage #rate
Mortgage rates have broken above a one-year high after stalling in the mid-sixes for two months. What will it take for mortgage rates to move lower?
See today's best rates.
As of July 30, Freddie Mac reported that the average 30-year fixed-rate mortgage rate was 6.66%. This is eight basis points higher than last week. At this time in July 2025, mortgage rates averaged 6.72%, six basis points higher
The average 15-year fixed mortgage rate this week was 6.04%, also up eight basis points from last week, and 19 basis points higher than this time last year.
#mortgage #rate
2 months ago
Wall Street just delivered one of its most impressive earnings weeks in history, with the five largest US banks reporting a combined net income of around $49 billion in the second quarter of 2026, up 39% year-over-year, and combined trading revenue close to $39 billion.
Global investment banking income managed to reach $61.4 billion in the first half of the year, a 24% increase over 2025, with **** eX's record-breaking IPO alone accounting for an estimated $500 million in underwriting fees for the banks leading it.
Morgan Stanley (NYSE:MS) came in with arguably the best result of the group. The company achieved an undeniable Q2 earnings beat, achieving record net revenue of $21.35 billion, an 8.6% surprise over the $19.65 billion consensus expectation, marking a 27.1% increase year-over-year and a 4% sequential gain. Diluted earnings per share increased 62.4% year-over-year to $3.46, solidly above Wall Street's $2.92 projection and boosting first-half return on tangible common equity (ROTCE) to an impressive 26.6%. Following the report, Freedom Broker upgraded Morgan Stanley to Buy from Hold on July 17, raising the price objective to $245 from $200.
Meanwhile, equities trading revenue reached an all-time high of $6.3 billion, roughly $1.9 billion higher than **** ysts had predicted, with Morgan Stanley (NYSE:MS) citing general strength across its equities franchise, especially "strength in Asia," a phrase now heard in almost every major bank's earnings call as the AI trade spreads far beyond US markets to Hong Kong, India, **** an, and South Korea.
While turbulent equities trading provided the headlines, Morgan Stanley (NYSE:MS)'s primary competitive advantage is its recurring Wealth and Investment Management franchise, which offers a high-margin buffer against market downturns. Wealth Management earned a record quarterly revenue of $8.9 billion, up 14% year-over-year, with a strong 30.5% pretax margin, driven by higher **** et management fees and net interest income. During the quarter, the company added a record $148 billion in net new **** ets, bringing total client **** ets throughout Wealth and Investment Management above the $10 trillion level.
#billion #NYSE #wealth
Global investment banking income managed to reach $61.4 billion in the first half of the year, a 24% increase over 2025, with **** eX's record-breaking IPO alone accounting for an estimated $500 million in underwriting fees for the banks leading it.
Morgan Stanley (NYSE:MS) came in with arguably the best result of the group. The company achieved an undeniable Q2 earnings beat, achieving record net revenue of $21.35 billion, an 8.6% surprise over the $19.65 billion consensus expectation, marking a 27.1% increase year-over-year and a 4% sequential gain. Diluted earnings per share increased 62.4% year-over-year to $3.46, solidly above Wall Street's $2.92 projection and boosting first-half return on tangible common equity (ROTCE) to an impressive 26.6%. Following the report, Freedom Broker upgraded Morgan Stanley to Buy from Hold on July 17, raising the price objective to $245 from $200.
Meanwhile, equities trading revenue reached an all-time high of $6.3 billion, roughly $1.9 billion higher than **** ysts had predicted, with Morgan Stanley (NYSE:MS) citing general strength across its equities franchise, especially "strength in Asia," a phrase now heard in almost every major bank's earnings call as the AI trade spreads far beyond US markets to Hong Kong, India, **** an, and South Korea.
While turbulent equities trading provided the headlines, Morgan Stanley (NYSE:MS)'s primary competitive advantage is its recurring Wealth and Investment Management franchise, which offers a high-margin buffer against market downturns. Wealth Management earned a record quarterly revenue of $8.9 billion, up 14% year-over-year, with a strong 30.5% pretax margin, driven by higher **** et management fees and net interest income. During the quarter, the company added a record $148 billion in net new **** ets, bringing total client **** ets throughout Wealth and Investment Management above the $10 trillion level.
#billion #NYSE #wealth
2 months ago
GE Vernova (NYSE: GEV) stock went on an absolute tear in the first half of 2026, surging 79.8%, according to data provided by S&P Global Market Intelligence.
Shortly after spinning off from General Electric (now GE Aerospace) in April 2024, the market realized that building massive artificial intelligence (AI) data centers isn't just a software or chip challenge – it's an energy challenge, and it's bigger than anything else.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Big tech companies suddenly needed astronomical amounts of immediate, reliable, round-the-clock electricity. As the world's largest manufacturer of natural gas turbines and a leading manufacturer of electrical transmission and distribution equipment, such as transformers and switchgear, GE Vernova had the right solution on scale.
The stock nearly doubled in 2025 and continued to rally through the first six months of 2026 as order book exploded. GE Vernova's latest numbers, however, have sent the stock tumbling. What does that mean for investors?
#NVIDIA #signal #vernova #challenge
Shortly after spinning off from General Electric (now GE Aerospace) in April 2024, the market realized that building massive artificial intelligence (AI) data centers isn't just a software or chip challenge – it's an energy challenge, and it's bigger than anything else.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Big tech companies suddenly needed astronomical amounts of immediate, reliable, round-the-clock electricity. As the world's largest manufacturer of natural gas turbines and a leading manufacturer of electrical transmission and distribution equipment, such as transformers and switchgear, GE Vernova had the right solution on scale.
The stock nearly doubled in 2025 and continued to rally through the first six months of 2026 as order book exploded. GE Vernova's latest numbers, however, have sent the stock tumbling. What does that mean for investors?
#NVIDIA #signal #vernova #challenge
2 months ago
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the "US Equity Strategy". A copy of the letter can be downloaded here. The Strategy lagged the S&P 500 Total Return Index in the quarter in terms of returns, but outperformed in dividend growth. Despite debate over capital cycle returns, AI remained the dominant market theme, expanding from early adoption to broader enterprise adoption. The firm continues to focus on high-dividend-growth companies while maintaining discipline around valuation and earnings durability. In addition, please check the Fund's top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, Bristol US Equity Strategy highlighted KLA Corporation (NASDAQ:KLAC) as a newly added position. KLA Corporation (NASDAQ:KLAC) is a global manufacturer and distributor of process control, process-enabling, and yield management solutions for the semiconductor and electronics industries. On July 21, 2026, KLA Corporation (NASDAQ:KLAC) closed at $217.56 per share, reflecting a market capitalization of $284.19 billion. KLA Corporation (NASDAQ:KLAC) posted a one-month return of -9.53%, while its shares gained 142.52% over the past 52 weeks.
Bristol US Equity Strategy stated the following regarding KLA Corporation (NASDAQ:KLAC) in its Q2 2026 investor update:
KLA Corporation (NASDAQ:KLAC) is a dominant provider of process-control and metrology equipment to the semiconductor industry, with a high market share that becomes more entrenched at each node transition. Metrology is the precision measurement and evaluation of nanoscale features; as chip-making and architecture grow more complex, the economic cost of yield loss rises sharply, which makes KLA's tools effectively non-discretionary for leading-edge manufacturers. Those tailwinds, combined with prudent management, support strong dividend growth.
KLA Corporation (NASDAQ:KLAC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 71 hedge fund portfolios held KLA Corporation (NASDAQ:KLAC) at the end of the first quarter, up from 67 in the previous quarter. While we acknowledge the potential of KLA Corporation (NASDAQ:KLAC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#NASDAQ #management #investor #quarter
In its Q2 2026 investor letter, Bristol US Equity Strategy highlighted KLA Corporation (NASDAQ:KLAC) as a newly added position. KLA Corporation (NASDAQ:KLAC) is a global manufacturer and distributor of process control, process-enabling, and yield management solutions for the semiconductor and electronics industries. On July 21, 2026, KLA Corporation (NASDAQ:KLAC) closed at $217.56 per share, reflecting a market capitalization of $284.19 billion. KLA Corporation (NASDAQ:KLAC) posted a one-month return of -9.53%, while its shares gained 142.52% over the past 52 weeks.
Bristol US Equity Strategy stated the following regarding KLA Corporation (NASDAQ:KLAC) in its Q2 2026 investor update:
KLA Corporation (NASDAQ:KLAC) is a dominant provider of process-control and metrology equipment to the semiconductor industry, with a high market share that becomes more entrenched at each node transition. Metrology is the precision measurement and evaluation of nanoscale features; as chip-making and architecture grow more complex, the economic cost of yield loss rises sharply, which makes KLA's tools effectively non-discretionary for leading-edge manufacturers. Those tailwinds, combined with prudent management, support strong dividend growth.
KLA Corporation (NASDAQ:KLAC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 71 hedge fund portfolios held KLA Corporation (NASDAQ:KLAC) at the end of the first quarter, up from 67 in the previous quarter. While we acknowledge the potential of KLA Corporation (NASDAQ:KLAC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#NASDAQ #management #investor #quarter
2 months ago
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the "US Equity Strategy". A copy of the letter can be downloaded here. The Strategy lagged the S&P 500 Total Return Index in the quarter in terms of returns, but outperformed in dividend growth. Despite debate over capital cycle returns, AI remained the dominant market theme, expanding from early adoption to broader enterprise adoption. The firm continues to focus on high-dividend-growth companies while maintaining discipline around valuation and earnings durability. In addition, please check the Fund's top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, Bristol US Equity Strategy highlighted KLA Corporation (NASDAQ:KLAC) as a newly added position. KLA Corporation (NASDAQ:KLAC) is a global manufacturer and distributor of process control, process-enabling, and yield management solutions for the semiconductor and electronics industries. On July 21, 2026, KLA Corporation (NASDAQ:KLAC) closed at $217.56 per share, reflecting a market capitalization of $284.19 billion. KLA Corporation (NASDAQ:KLAC) posted a one-month return of -9.53%, while its shares gained 142.52% over the past 52 weeks.
Bristol US Equity Strategy stated the following regarding KLA Corporation (NASDAQ:KLAC) in its Q2 2026 investor update:
KLA Corporation (NASDAQ:KLAC) is a dominant provider of process-control and metrology equipment to the semiconductor industry, with a high market share that becomes more entrenched at each node transition. Metrology is the precision measurement and evaluation of nanoscale features; as chip-making and architecture grow more complex, the economic cost of yield loss rises sharply, which makes KLA's tools effectively non-discretionary for leading-edge manufacturers. Those tailwinds, combined with prudent management, support strong dividend growth.
KLA Corporation (NASDAQ:KLAC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 71 hedge fund portfolios held KLA Corporation (NASDAQ:KLAC) at the end of the first quarter, up from 67 in the previous quarter. While we acknowledge the potential of KLA Corporation (NASDAQ:KLAC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#investor
In its Q2 2026 investor letter, Bristol US Equity Strategy highlighted KLA Corporation (NASDAQ:KLAC) as a newly added position. KLA Corporation (NASDAQ:KLAC) is a global manufacturer and distributor of process control, process-enabling, and yield management solutions for the semiconductor and electronics industries. On July 21, 2026, KLA Corporation (NASDAQ:KLAC) closed at $217.56 per share, reflecting a market capitalization of $284.19 billion. KLA Corporation (NASDAQ:KLAC) posted a one-month return of -9.53%, while its shares gained 142.52% over the past 52 weeks.
Bristol US Equity Strategy stated the following regarding KLA Corporation (NASDAQ:KLAC) in its Q2 2026 investor update:
KLA Corporation (NASDAQ:KLAC) is a dominant provider of process-control and metrology equipment to the semiconductor industry, with a high market share that becomes more entrenched at each node transition. Metrology is the precision measurement and evaluation of nanoscale features; as chip-making and architecture grow more complex, the economic cost of yield loss rises sharply, which makes KLA's tools effectively non-discretionary for leading-edge manufacturers. Those tailwinds, combined with prudent management, support strong dividend growth.
KLA Corporation (NASDAQ:KLAC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 71 hedge fund portfolios held KLA Corporation (NASDAQ:KLAC) at the end of the first quarter, up from 67 in the previous quarter. While we acknowledge the potential of KLA Corporation (NASDAQ:KLAC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#investor
2 months ago
Sharplink Inc. (NASDAQ:SBET) is one of the 10 best stocks under $10 that could triple.
On June 30, Sharplink Inc. (NASDAQ:SBET) disclosed that it had purchased 10,000 Ether at an average price of $1,611 per ETH. This lifts its ***** ulative holdings to 886,725 tokens. The company also executed an open market buyback of more than 2.13 million of its common shares at an average rate of $4.69 per share, under its current stock repurchase program.
The company's Chief Executive Officer, Joseph Chalom, reflected on Sharplink's recently concluded $75 million registered direct offering, which he believes has improved the company's financial standing and facilitated its dynamic strategy for ETH treasury management. He further stated:
"Our capital allocation philosophy is disciplined and straightforward: every financing decision we make is based on our long-term objective to increase ETH per share."
Earlier on June 22, SharpLink Inc. (NASDAQ:SBET) revealed that it had signed an SPA with an institutional investor for the sale and purchase of more than 10 million of its common shares. The agreement also included attached warrants to buy common stock up to the designated amount. The underlying combined price was $7.49 per share and warrant, representing a 41% premium over the prevailing market price.
On June 30, Sharplink Inc. (NASDAQ:SBET) disclosed that it had purchased 10,000 Ether at an average price of $1,611 per ETH. This lifts its ***** ulative holdings to 886,725 tokens. The company also executed an open market buyback of more than 2.13 million of its common shares at an average rate of $4.69 per share, under its current stock repurchase program.
The company's Chief Executive Officer, Joseph Chalom, reflected on Sharplink's recently concluded $75 million registered direct offering, which he believes has improved the company's financial standing and facilitated its dynamic strategy for ETH treasury management. He further stated:
"Our capital allocation philosophy is disciplined and straightforward: every financing decision we make is based on our long-term objective to increase ETH per share."
Earlier on June 22, SharpLink Inc. (NASDAQ:SBET) revealed that it had signed an SPA with an institutional investor for the sale and purchase of more than 10 million of its common shares. The agreement also included attached warrants to buy common stock up to the designated amount. The underlying combined price was $7.49 per share and warrant, representing a 41% premium over the prevailing market price.
2 months ago
Google is losing employees to rival artificial-intelligence labs and may be falling behind in the race to build advanced AI models. One place it definitely isn’t falling behind: Search traffic.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
2 months ago
Century Therapeutics, Inc. (NASDAQ:IPSC) is one of the 10 Fastest Growing Tech Penny Stocks to Buy.
On July 9, 2026, Century Therapeutics, Inc. (NASDAQ:IPSC) announced that its abstracts were accepted for oral presentations at two upcoming scientific congresses. Both presentations will highlight CNTY-813, Century's iPSC-derived islet replacement therapy program engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes.
The presentations are scheduled for the 62nd Annual Meeting of the European **** ociation for the Study of Diabetes, taking place September 28-October 2, 2026 in Milan, Italy, and the Breakthrough T1D Clinical & Research Congress 2026, taking place October 9-11, 2026 in Philadelphia, Pennsylvania. Century said CNTY-813 is designed to enable durable engraftment without chronic systemic immunosuppression, and the company is targeting an IND submission in the fourth quarter of 2026.
On June 9, Century Therapeutics announced new preclinical data for CNTY-813 at the American Diabetes **** ociation Scientific Sessions. In preclinical models, the therapy demonstrated durable glucose control for over eight months and maintained insulin secretion under allogeneic immune pressure without immunosuppression. CEO Brent Pfeiffenberger said the data advance the company's case for a "potentially functional cure" for type 1 diabetes, while noting that the IND submission remains on track for the fourth quarter of 2026 and initial clinical data are anticipated in the second half of 2027.
Century Therapeutics, Inc. (NASDAQ:IPSC) develops allogeneic cell therapies for the treatment of solid tumors, hematological malignancies, and autoimmune diseases.
On July 9, 2026, Century Therapeutics, Inc. (NASDAQ:IPSC) announced that its abstracts were accepted for oral presentations at two upcoming scientific congresses. Both presentations will highlight CNTY-813, Century's iPSC-derived islet replacement therapy program engineered with Allo-Evasion™ 5.0 for patients with type 1 diabetes.
The presentations are scheduled for the 62nd Annual Meeting of the European **** ociation for the Study of Diabetes, taking place September 28-October 2, 2026 in Milan, Italy, and the Breakthrough T1D Clinical & Research Congress 2026, taking place October 9-11, 2026 in Philadelphia, Pennsylvania. Century said CNTY-813 is designed to enable durable engraftment without chronic systemic immunosuppression, and the company is targeting an IND submission in the fourth quarter of 2026.
On June 9, Century Therapeutics announced new preclinical data for CNTY-813 at the American Diabetes **** ociation Scientific Sessions. In preclinical models, the therapy demonstrated durable glucose control for over eight months and maintained insulin secretion under allogeneic immune pressure without immunosuppression. CEO Brent Pfeiffenberger said the data advance the company's case for a "potentially functional cure" for type 1 diabetes, while noting that the IND submission remains on track for the fourth quarter of 2026 and initial clinical data are anticipated in the second half of 2027.
Century Therapeutics, Inc. (NASDAQ:IPSC) develops allogeneic cell therapies for the treatment of solid tumors, hematological malignancies, and autoimmune diseases.
2 months ago
Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures. Taiwan Semiconductor, Goldman Sachs, JPMorgan Chase, GE Aerospace headline the first big earnings week. Key inflation reports and Federal Reserve Chairman Kevin Warsh also are on tap.
The stock market had a mixed but generally positive week, even as oil prices rebounded. The S&P 500 and Nasdaq had strong gains while the Dow Jones edged lower, but right at all-time highs.
Cisco Systems (CSCO), Robinhood Markets (HOOD), Sandisk (SNDK), Micron Technology (MU) and Nvidia (NVDA) are stocks around buy areas. Meanwhile, ******* e Exploration Technologies (SPCX), better known as ******* eX, hit a new low.
Nvidia chipmaker Taiwan Semiconductor (TSM) and ASML (ASML) kick off chip earnings, while Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan Chase (JPM) lead a slew of big banks. GE Aerospace (GE), UnitedHealth (UNH), J.B. Hunt Transport Services (JBHT), United Airlines (UAL) and American Airlines (AAL) also are ahead. All are setting up in various fashions.
On Tuesday, investors will get the June CPI inflation report, with PPI inflation on Wednesday. Fed chief Warsh will testify before Congress on those two days.
The stock market had a mixed but generally positive week, even as oil prices rebounded. The S&P 500 and Nasdaq had strong gains while the Dow Jones edged lower, but right at all-time highs.
Cisco Systems (CSCO), Robinhood Markets (HOOD), Sandisk (SNDK), Micron Technology (MU) and Nvidia (NVDA) are stocks around buy areas. Meanwhile, ******* e Exploration Technologies (SPCX), better known as ******* eX, hit a new low.
Nvidia chipmaker Taiwan Semiconductor (TSM) and ASML (ASML) kick off chip earnings, while Goldman Sachs (GS), Morgan Stanley (MS), JPMorgan Chase (JPM) lead a slew of big banks. GE Aerospace (GE), UnitedHealth (UNH), J.B. Hunt Transport Services (JBHT), United Airlines (UAL) and American Airlines (AAL) also are ahead. All are setting up in various fashions.
On Tuesday, investors will get the June CPI inflation report, with PPI inflation on Wednesday. Fed chief Warsh will testify before Congress on those two days.
